{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T01:33:32Z","timestamp":1790040812261,"version":"4.0.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"DOI":"10.1186\/s12886-025-03972-6","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T22:05:14Z","timestamp":1751493914000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy of combined topical nepafenac 0.3% with suprachoroidal injection of triamcinolone acetonide using a modified custom needle in pseudopkakic cystoid macular edema"],"prefix":"10.1186","volume":"25","author":[{"given":"Amin E.","family":"Nawar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,3]]},"reference":[{"issue":"9","key":"3972_CR1","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/j.jcrs.2007.05.013","volume":"33","author":"BA Henderson","year":"2007","unstructured":"Henderson BA, Kim JY, Ament CS, Ferrufino-Ponce ZK, Grabowska A, Cremers SL. Clinical pseudophakic cystoid macular edema: risk factors for development and duration after treatment. J Cataract Refract Surg. 2007;33(9):1550\u20138. https:\/\/doi.org\/10.1016\/j.jcrs.2007.05.013.","journal-title":"J Cataract Refract Surg"},{"issue":"2","key":"3972_CR2","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.ophtha.2015.10.001","volume":"123","author":"CJ Chu","year":"2016","unstructured":"Chu CJ, Johnston RL, Buscombe C, Sallam AB, Mohamed Q, Yang YC, et al. Risk factors and in- cidence of macular edema after cataract surgery: a database study of 81984 eyes. Ophthalmology. 2016;123(2):316\u201323. https:\/\/doi.org\/10.1016\/j.ophtha.2015.10.001.","journal-title":"Ophthalmology"},{"issue":"3","key":"3972_CR3","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/02713680601160610","volume":"32","author":"I Perente","year":"2007","unstructured":"Perente I, Utine CA, Ozturker C, Cakir M, Kaya V, Eren H, et al. Evaluation of macular changes after uncomplicated phacoemulsification surgery by optical coherence tomography. Curr Eye Res. 2007;32(3):241\u20137. https:\/\/doi.org\/10.1080\/02713680601160610.","journal-title":"Curr Eye Res"},{"issue":"4","key":"3972_CR4","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/eye.1993.107","volume":"7","author":"P Desai","year":"1993","unstructured":"Desai P. The national cataract surgery survey: II. Clinical outcomes. Eye (Lond). 1993;7(4):489\u201394. https:\/\/doi.org\/10.1038\/eye.1993.107.","journal-title":"Eye (Lond)"},{"key":"3972_CR5","doi-asserted-by":"publisher","first-page":"S203","DOI":"10.1016\/s0039-6257(02)00294-1","volume":"47","author":"K Miyake","year":"2002","unstructured":"Miyake K, Ibaraki N. Prostaglandins and cystoid macular edema. Surv Ophthalmol. 2002;47:S203\u201318. https:\/\/doi.org\/10.1016\/s0039-6257(02)00294-1.","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"3972_CR6","doi-asserted-by":"publisher","first-page":"233","DOI":"10.2165\/00002018-200225040-00002","volume":"25","author":"BI Gaynes","year":"2002","unstructured":"Gaynes BI, Fiscella R. Topical nonsteroidal anti-inflammatory drugs for ophthalmic use: a safety review. Drug Saf. 2002;25(4):233\u201350. https:\/\/doi.org\/10.2165\/00002018-200225040-00002.","journal-title":"Drug Saf"},{"issue":"2","key":"3972_CR7","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0014-2999(84)90720-9","volume":"106","author":"A Perianin","year":"1984","unstructured":"Perianin A, Roch-Arveiller M, Giroud JP, Hakim J. In vivo effects of indomethacin and flurbiprofen on the locomotion of neutrophils elicited by immune and non-immune inflammation in the rat. Eur J Pharmacol. 1984;106(2):327\u201333. https:\/\/doi.org\/10.1016\/0014-2999(84)90720-9.","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"3972_CR8","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/s0161-6420(87)33424-4","volume":"94","author":"JP Guzek","year":"1987","unstructured":"Guzek JP, Holm M, Cotter JB, Cameron JA, Rademaker WJ, Wissinger DH, et al. Risk factors for intraoperative complications in 1000 extracapsular cataract cases. Ophthalmology. 1987;94(5):461\u20136. https:\/\/doi.org\/10.1016\/s0161-6420(87)33424-4.","journal-title":"Ophthalmology"},{"issue":"6","key":"3972_CR9","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.jcrs.2009.12.030","volume":"36","author":"HF Ahmadabadi","year":"2010","unstructured":"Ahmadabadi HF, Mohammadi M, Beheshtnejad H, Mirshahi A. Effect of intravitreal triamcinolone acetonide injection on central macular thickness in diabetic patients having phacoemulsification. J Cataract Refract Surg. 2010;36(6):917\u201322. https:\/\/doi.org\/10.1016\/j.jcrs.2009.12.030.","journal-title":"J Cataract Refract Surg"},{"issue":"2","key":"3972_CR10","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/s0002-9394(02)01938-4","volume":"135","author":"N Benhamou","year":"2003","unstructured":"Benhamou N, Massin P, Haouchine B, Audren F, Tadayoni R, Gaudric A. Intravitreal triamcinolone for refractory pseudophakic macular edema. Am J Ophthalmol. 2003;135(2):246\u20139. https:\/\/doi.org\/10.1016\/s0002-9394(02)01938-4.","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"3972_CR11","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/s0002-9394(03)00230-7","volume":"136","author":"JB Jonas","year":"2003","unstructured":"Jonas JB, Kreissig I, Degenring RF. Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema. Am J Ophthalmol. 2003;136(2):384\u20136. https:\/\/doi.org\/10.1016\/s0002-9394(03)00230-7.","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"3972_CR12","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1159\/000093796","volume":"38","author":"JB Jonas","year":"2006","unstructured":"Jonas JB. Intravitreal triamcinolone acetonide: a change in a paradigm. Ophthalmic Res. 2006;38(4):218\u201345. https:\/\/doi.org\/10.1159\/000093796.","journal-title":"Ophthalmic Res"},{"key":"3972_CR13","doi-asserted-by":"publisher","unstructured":"Dang Y, Mu Y, Li L, Mu Y, Liu S, Zhang C, et al. Comparison of dexamethasone intravitreal implant and intravitreal triamcinolone acetonide for the treatment of pseudophakic cystoid macular edema in diabetic patients.\u00a0Drug Design, Develop Ther. 2014:1441\u20131449.\u200f https:\/\/doi.org\/10.2147\/DDDT.S66611.","DOI":"10.2147\/DDDT.S66611"},{"key":"3972_CR14","doi-asserted-by":"publisher","first-page":"364143","DOI":"10.1155\/2014\/364143","volume":"2014","author":"D Zalewski","year":"2014","unstructured":"Zalewski D, Raczy\u0144ska D, Raczy\u0144ska K. Five-month observation of persistent diabetic macular edema after intravitreal injection of Ozurdex implant. Mediators Inflamm. 2014;2014:364143. https:\/\/doi.org\/10.1155\/2014\/364143.","journal-title":"Mediators Inflamm."},{"issue":"3","key":"3972_CR15","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1159\/000357275","volume":"51","author":"M Parravano","year":"2014","unstructured":"Parravano M, Oddone F, Boccassini B, Giorno P, Chiaravalloti A, Tedeschi M, et al. Exploring the morphological and functional retinal changes after dexamethasone intravitreal implant (Ozurdex\u00ae) in macular edema due to retinal vein occlusion. Ophthalmic Res. 2014;51(3):153\u2013216. https:\/\/doi.org\/10.1159\/000357275.","journal-title":"Ophthalmic Res"},{"issue":"3","key":"3972_CR16","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.ajo.2013.11.016","volume":"157","author":"F Pichi","year":"2014","unstructured":"Pichi F, Specchia C, Vitale L, Lembo A, Morara M, Veronese C, et al. Combination therapy with dexamethasone intravitreal implant and macular grid laser in patients with branch retinal vein occlusion. Am J Ophthalmol. 2014;157(3):607\u201315. https:\/\/doi.org\/10.1016\/j.ajo.2013.11.016.","journal-title":"Am J Ophthalmol"},{"issue":"13","key":"3972_CR17","first-page":"5259","volume":"55","author":"HF Edelhauser","year":"2014","unstructured":"Edelhauser HF, Verhoeven RS, Burke B, Struble CB, Patel SR. Intraocular distribution and targeting of triamcinolone acetonide suspension administered into the suprachoroidal space. Invest Ophthalmol Vis Sci. 2014;55(13):5259.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"3972_CR18","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1167\/iovs.13-11747","volume":"54","author":"BC Gilger","year":"2013","unstructured":"Gilger BC, Abarca EM, Salmon JH, Patel S. Treatment of acute posterior uveitis in a porcine model by injection of triamcinolone acetonide into the suprachoroidal space using microneedles. Invest Ophthalmol Vis Sci. 2013;54(4):2483\u201392. https:\/\/doi.org\/10.1167\/iovs.13-11747.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3972_CR19","doi-asserted-by":"publisher","unstructured":"Yeh S, Kurup SK, Wang RC, Foster CS, Noronha G, Nguyen QD, et al. Suprachoroidal injection of triamcinolone acetonide, CLS-TA, for macular edema due to noninfectious uveitis: a randomized, phase 2 study (DOGWOOD). Retina. 2019;39(10):1880\u20138. https:\/\/doi.org\/10.1097\/IAE.0000000000002279.","DOI":"10.1097\/IAE.0000000000002279"},{"issue":"4","key":"3972_CR20","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.oret.2017.07.013","volume":"2","author":"PA Campochiaro","year":"2018","unstructured":"Campochiaro PA, Wykoff CC, Brown DM, Boyer DS, Barakat M, Taraborelli D, et al. Suprachoroidal triamcinolone acetonide for retinal vein occlusion: results of the tanzanite study. Ophthalmol Retin. 2018;2(4):320\u20138. https:\/\/doi.org\/10.1016\/j.oret.2017.07.013.","journal-title":"Ophthalmol Retin"},{"key":"3972_CR21","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.2147\/OPTH.S361636","volume":"1139","author":"AE Nawar","year":"2022","unstructured":"Nawar AE. Modified microneedle for suprachoroidal injection of triamcinolone acetonide combined with intravitreal injection of ranibizumab in branch retinal vein occlusion patients. Clin Ophthalmol. 2022;1139:1151. https:\/\/doi.org\/10.2147\/OPTH.S361636.","journal-title":"Clin Ophthalmol"},{"key":"3972_CR22","doi-asserted-by":"publisher","first-page":"3831","DOI":"10.2147\/OPTH.S391319","volume":"3821","author":"AE Nawar","year":"2022","unstructured":"Nawar AE. Effectiveness of Suprachoroidal Injection of Triamcinolone Acetonide in Resistant Diabetic Macular Edema Using a Modified Microneedle. Clin Ophthalmol. 2022;3821:3831. https:\/\/doi.org\/10.2147\/OPTH.S391319.","journal-title":"Clin Ophthalmol"},{"issue":"12","key":"3972_CR23","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1016\/s0886-3350(03)00233-5","volume":"29","author":"DS Rho","year":"2003","unstructured":"Rho DS. Treatment of acute pseudophakic cystoid macular edema: Diclofenac versus ketorolac. J Cataract Refract Surg. 2003;29(12):2378\u201384. https:\/\/doi.org\/10.1016\/s0886-3350(03)00233-5.","journal-title":"J Cataract Refract Surg"},{"key":"3972_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004239","author":"S Sivaprasad","year":"2012","unstructured":"Sivaprasad S, Bunce C, Crosby-Nwaobi R. Non-steroidal anti-inflammatory agents for treating cystoid macular oedema following cataract surgery. Cochrane Database Syst Rev. 2012. https:\/\/doi.org\/10.1002\/14651858.CD004239.","journal-title":"Cochrane Database Syst Rev"},{"key":"3972_CR25","doi-asserted-by":"publisher","first-page":"s243","DOI":"10.1111\/j.1755-3768.2008.6417.x","volume":"86","author":"H Suleman","year":"2008","unstructured":"Suleman H, Mathew M, Lakshmanan A, Abedin A, Orr G. Orbital floor triamcinolone acetonide in the treatment of pseudophakic cystoid macular oedema. Acta Ophthalmol. 2008;86:s243. https:\/\/doi.org\/10.1111\/j.1755-3768.2008.6417.x.","journal-title":"Acta Ophthalmol"},{"issue":"8","key":"3972_CR26","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1136\/bjo.2006.090340","volume":"90","author":"DJ Rhee","year":"2006","unstructured":"Rhee DJ, Peck RE, Belmont J, Martidis A, Liu M, Chang J, et al. Intraocular pressure alterations following intravitreal triamcinolone acetonide. Br J Ophthalmol. 2006;90(8):999\u20131003. https:\/\/doi.org\/10.1136\/bjo.2006.090340.","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"3972_CR27","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.12669\/pjms.345.13174","volume":"34","author":"PS Mahar","year":"2018","unstructured":"Mahar PS, Memon AS, Fahim MF. Raised intraocular pressure following intravitreal triamcinolone acetonide in diabetic versus non-diabetic patients. Pak J Med Sci. 2018;34(5):1110\u20134. https:\/\/doi.org\/10.12669\/pjms.345.13174.","journal-title":"Pak J Med Sci."},{"issue":"6","key":"3972_CR28","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1089\/jop.2019.0126","volume":"36","author":"V Kansara","year":"2020","unstructured":"Kansara V, Muya L, Wan CR, Ciulla TA. Suprachoroidal delivery of viral and nonviral gene therapy for retinal diseases. J Ocul Pharmacol Ther. 2020;36(6):384\u201392. https:\/\/doi.org\/10.1089\/jop.2019.0126.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"6","key":"3972_CR29","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1080\/17425247.2021.1867532","volume":"18","author":"SE Hancock","year":"2021","unstructured":"Hancock SE, Wan CR, Fisher NE, Andino RV, Ciulla TA. Biomechanics of suprachoroidal drug delivery: from benchtop to clinical investigation in ocular therapies. Expert Opin Drug Deliv. 2021;18(6):777\u201388. https:\/\/doi.org\/10.1080\/17425247.2021.1867532.","journal-title":"Expert Opin Drug Deliv"},{"key":"3972_CR30","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.omtm.2020.01.002","volume":"16","author":"G Yiu","year":"2020","unstructured":"Yiu G, Chung SH, Mollhoff IN, Nguyen UT, Thomasy SM, Yoo J, et al. Suprachoroidal and Subretinal Injections of AAV Using Transscleral Microneedles for Retinal Gene Delivery in Nonhuman Primates. Mol Ther Methods Clin Dev. 2020;16:179\u201391. https:\/\/doi.org\/10.1016\/j.omtm.2020.01.002.","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"3","key":"3972_CR31","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0161-6420(98)93018-4","volume":"105","author":"L Rossetti","year":"1998","unstructured":"Rossetti L, Chaudhuri J, Dickersin K. Medical prophylaxis and treatment of cystoid macular edema after cataract surgery. The results of a meta-analysis. Ophthalmology. 1998;105(3):397\u2013405. https:\/\/doi.org\/10.1016\/S0161-6420(98)93018-4.","journal-title":"Ophthalmology"},{"issue":"4","key":"3972_CR32","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.ajo.2008.04.036","volume":"146","author":"JR Wittpenn","year":"2008","unstructured":"Wittpenn JR, Silverstein S, Heier J, Kenyon KR, Hunkeler JD, Earl M. A randomized, masked comparison of topical ketorolac 0.4% plus steroid vs steroid alone in low-risk cataract surgery patients. Am J Ophthalmol. 2008;146(4):554\u201360. https:\/\/doi.org\/10.1016\/j.ajo.2008.04.036.","journal-title":"Am J Ophthalmol."},{"issue":"9","key":"3972_CR33","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1016\/j.jcrs.2006.04.009","volume":"32","author":"ED Donnenfeld","year":"2006","unstructured":"Donnenfeld ED, Perry HD, Wittpenn JR, Solomon R, Nattis A, Chou T. Preoperative ketorolac tromethamine 0.4% in phacoemulsification outcomes: pharmacokinetic-response curve. J Cataract Refract Surg. 2006;32(9):1474\u201382. https:\/\/doi.org\/10.1016\/j.jcrs.2006.04.009.","journal-title":"J Cataract Refract Surg."},{"issue":"2","key":"3972_CR34","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000317067","volume":"225","author":"IP Chatziralli","year":"2011","unstructured":"Chatziralli IP, Papazisis L, Sergentanis TN. Ketorolac plus tobramycin\/dexamethasone versus tobramycin\/ dexamethasone after uneventful phacoemulsification surgery: a randomized controlled trial. Ophthalmologica. 2011;225(2):89\u201394. https:\/\/doi.org\/10.1159\/000317067.","journal-title":"Ophthalmologica"},{"issue":"1","key":"3972_CR35","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jcrs.2007.08.034","volume":"34","author":"DR Almeida","year":"2008","unstructured":"Almeida DR, Johnson D, Hollands H, Smallman D, Baxter S, Eng KT, et al. Effect of prophylactic nonsteroidal antiinflammatory drugs on cystoid macular edema assessed using optical coherence tomography quantification of total macular volume after cataract surgery. J Cataract Refract Surg. 2008;34(1):64\u20139. https:\/\/doi.org\/10.1016\/j.jcrs.2007.08.034.","journal-title":"J Cataract Refract Surg"},{"key":"3972_CR36","doi-asserted-by":"publisher","first-page":"101254","DOI":"10.1016\/j.ajoc.2021.101254","volume":"25","author":"A Marashi","year":"2022","unstructured":"Marashi A, Zazo A. A manually made needle for treating Pseudophakic cystoid macular edema by injecting triamcinolone acetonide in the suprachoroidal space: a case report. Am J Ophthalmol Case Rep. 2022;25:101254. https:\/\/doi.org\/10.1016\/j.ajoc.2021.101254.","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"3","key":"3972_CR37","doi-asserted-by":"publisher","first-page":"765","DOI":"10.4103\/ijo.IJO_1464_20","volume":"69","author":"A Oli","year":"2021","unstructured":"Oli A, Waikar S. Modified inexpensive needle for suprachoroidal triamcinolone acetonide injections in pseudophakic cystoid macular edema. Indian J Ophthalmol. 2021;69(3):765. https:\/\/doi.org\/10.4103\/ijo.IJO_1464_20.","journal-title":"Indian J Ophthalmol"},{"issue":"1","key":"3972_CR38","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2147\/opth.s2359","volume":"2","author":"MS Kocabora","year":"2008","unstructured":"Kocabora MS, Yilmazli C, Taskapili M, Gulkilik G, Durmaz S. Development of ocular hypertension and persistent glaucoma after intravitreal injection of triamcinolone. Clin Ophthalmol. 2008;2(1):167\u201371. https:\/\/doi.org\/10.2147\/opth.s2359.","journal-title":"Clin Ophthalmol"},{"issue":"12","key":"3972_CR39","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1016\/j.ophtha.2011.05.014","volume":"118","author":"JA Haller","year":"2011","unstructured":"Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Ozurdex GENEVA Study Group. Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion: twelve-month study results. Ophthalmology. 2011;118(12):2453\u201360. https:\/\/doi.org\/10.1016\/j.ophtha.2011.05.014.","journal-title":"Ophthalmology."}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-03972-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-025-03972-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-03972-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T22:05:15Z","timestamp":1751493915000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-025-03972-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,3]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3972"],"URL":"https:\/\/doi.org\/10.1186\/s12886-025-03972-6","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,3]]},"assertion":[{"value":"16 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethical Committee of the Faculty of Medicine, Tanta University, Egypt (approval code 35624\/8\/22). All procedures were performed under the tenets of the 1964 Helsinki Declaration. Informed consent was obtained from every patient. The study was prospectively registered with clinical trial.gov ID (NCT04690608) in 27\u201312-2020. The study adheres to the CONSORT guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"350"}}